Quiz (3rd midterm) Flashcards
I. Breast disease
A. Common symptoms (not specific for cancer, fibrotic growths, cysts; however, the older the patient, the greater the likelihood that it is malignant)
- Pain
- Palbable masses
- Nipple discharge
B. Mammography
• Start screening at ~40 yrs because younger women have denser breast tissue making it difficult to identify a mass
- It detects density
- Can show architectural distortions
- Identifies calcification
- Changes over time and these changes can indication pathologies such as cancers
- ~10% of breast cancers that are not detected by mammography, can be detected by palpitation
- Can use imaging to help guide biopsy needle in order to sample a growth.
- 85-90% predictive
II. Acute mastitis
- Can cause breast abscesses and necrosis
- Typically associated with women who are breast feeding.
- Can be caused by plugged ducts
- Can be infectious or non-infectious
III. Fat necrosis
• Usually associated with trauma (from a seat belt during an accident)
IV. Breast cysts
- Fibrolytic changes
- Higher risk of breast cancer
- Occurs 20-40 years old
- Doesn’t typically occur after menopause
- Can calcify
- Can look like cancer on mammogram
V. Benign neoplasm
- Fibroadenomas are the most common
- Mostly connective tissue
- Well circumscribed
- Don’t typically remove unless uncomfortable.
VI. Breast carcinoma
• Rarely occurs
Breast cancer symptoms, prognosis
A. Symptoms:
• Pain
• Masses (assessed by palpitation, mammography, ultrasound, MRI, or tissue biopsied)
B. Prognosis
• Based on size, axillary node status, and distant metastasis
• 5 year Survival rate of stage 0 (early stage)=92%, stage IV (late)= 13%
• If tumor expresses estrogen/progesterone receptors, it often responds to hormonal treatment
C. Types of breast cancer
- Invasive carcinoma: 75-85%
- Most are ductal and the incidence increases with age & have invasive and non-invasive types
- Can do lumpectomies to remove smaller masses.
D. Benign epithelial lesions
-typically fibrocytic changes (e.g.,60% of women have microscopic cysts associated with epithelial tissue.
VII. Cervical Cancers
• HPV (human papillomavirus)- associated squamous cell neoplasm represents most cervical cancers -use pap smear to detect early • Risk factors -multiple sex partners -Immunosuppression -early age of first sexual contact -oral contraception for >5 years -nicotine use
VIII. Endometrium
A. Polyps
- Causes:
• Hypertension
• Obesity
• Late menopause
B. Endometrial cancer (adenocarcinoma)
- Risks
• Obesity
• Diabetes
• Hypertension
B. Endometrial cancer (adenocarcinoma) tx
- Treatment
• Hysterectomy-treatment of choice
• Radiation/chemotherapy adjunctive
C. Endometritis (infections)
-cause is often IUDs (intrauterine devices)
D. Endometrial hyperplasia—can progress to a cancer
- Exaggerated responses due to excessive estrogen (e.g., excessive ovarian activity)
- Treatment:
- Progesterone
- Hysterectomy
IX. Ovarian masses (ovary cancer is amass )
A. Types:
• Non-neoplastic cysts (e.g., follicular)
• Neoplastic: e.g., endometroioid
• Most are sporadic
• Contraceptives can decrease risk
• Treatment:
-total hysterectomy + removal of surrounding tissue + chemotherapy
IX. Ovarian masses (ovary cancer is amass )
A. symtoms:
• Pelvic pain
• Pelvic mass
• Abdominal bleeding
C. Unlike cervical cancer, there is no effective screening for ovarian cancer
A. Estrogens and Progestins
- Natural estrogens are steroid hormones—synthesized estrogens may be non-steroidal
- They cross cell membranes and activate estrogen receptors inside cell—modulate expression of genes
. The menstrual cycle:
- Menstrual stage—menses
- Follicular stage—proliferative
- Luteal stage—secretory
- As populations age, they …
- As populations age, they spend more time in menopause (females) or andropause (males
- Estrogens:
a. Natural
- Estrone (predominant during menopause)- E1
- Estradiol (predominant during productive years)—E2
- Estratriol (predominant during pregnancy)—E3
- Estrogens:
a. synthetic
- Steroidal: ethinyl estradiol
* Non-steroidal: diethylstilbesterol
c. Physiological functions of estrogen
- Sexual maturity
- Increased CNS excitability (seizure inducing?)
- Increased endometrial and uterine growth
- Maintain skin elasticity
- Reduce bone adsorption
- Increase blood coagulability
d. Clinical uses of estrogen
• Primary hypogonadism
• Postmenopausal
(1) Guidelines for use
• Always use the smallest dose for the shortest period of time possible
• Sometimes local creams are preferred to minimize exposure
e. Adverse effects of estrogen
- Postmenopausal bleeding
- Nausea, breast tenderness
- Migraines
- Hypertension
- Hyperpigmentation (especially around eyes)
- Increases some cancers (e.g.. breast and endometrial)
f. contraindicated: for estrogen
- Liver disease (slows metabolism)
- Breast/endometrial cancers
- Thrombolytic disorders
Progestin
• Made from cholesterol
• Present in males, but less than females
a. Progesterone (natural)—most important progestin in human
• Precursor to estrogen, androgen and adrenalcortical steroids (e.g., cortisol)
• Also precursor to testosterone and estradiol
b. Synthetic progestins
c. Half life= 5 min. (very short acting)
Progestin effects
d. Effects:
• Increase fat deposition
• Decrease CNS excitability (e.g., antiseizure—opposite of estrogen)
• Increase aldosterone—increase Na+ retention—increase BP—increase water retention and blood volume
• Increase body temperature
Clinical uses of progestin
and contraindications
- Replacement therapy
- Oral contraception
- Long-term ovarian suppression (e.g., dysmenorrhea or endometriosis)—in contrast to estrogens, no problem with bleeding or clotting
- Contraindications:
- Breast cancer is a risk
- Severe hypertension or heart disease is risk
Combination contraception :
progesterone+ estrogen
- Decreases ovulation (approaching 100%)
* Decreases conception and implantation
Progestin only effects
. Progestin only (less effective, ~80-90%)
• Decreases ovulation 50-80%
• Thickens mucus and reduces sperm penetration
• Impairs implantation
Delivery forms
- Combinations:
- Monophasics- constant doses of both estrogen and progesterone
- Biphasic- dosage of one or both change one time during cycle
- Triphasic-dosages change 2 times
- Progestin only—referred to as the “minipill” (no estrogen); fewer side effects, but less effective
- Implantable
- Injections (i.m., sustained effects)
- Intravaginal rings
- IUDs with and without estrogen/progestin
- Transdermal combinations
Side effects of combination
Side effects of combinations
• Reduced ovarian functions and size
• Increased breast size and tenderness
• Increased thrombolytic events
• Increased heart rate and BP
• Hyperpigmentation, especially around the eye
• Mild nausea, breakthrough bleeding, headaches
• May interact with antibiotics that disrupt G.I. normal flora (e.g., wide spectrum antibiotics such as amoxicillin)—normal absorption of contraceptives from GI system is dependent on these flora
Contraception uses
- Oral contraception
- Menstrual disorders, irregularity, heavy discharge
- Acne
Tamoxifen
• Tamoxifen—blocks actions of estrogen in breast-used to treat breast cancers
Mifepristone
• Mifepristone- morning after contraceptive: blocks progesterone and glucocorticoid receptors